A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study

NCT03450187 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections

Interventions

DRUG: TP-271

Sponsor

Tetraphase Pharmaceuticals, Inc

Collaborators

[object Object]